Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, CSL commits to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
CSL partnered with industry and advocacy organizations in Germany to create a bold, visual demonstration of why primary immun…
The global biotech company is open to innovation and has opened a new line of communication with researchers: Yet2, a platfor…
Partnering with Uplifting Athletes, Michael A. Taylor of the Minnesota Twins sets out to hit 30 home runs and raise $150,000 …
For the immunocompromised, wearing a mask in 2023 can invite comments and criticism. Here are three tips for handling pushbac…
An organ transplant can save a person’s life, but to be successful, the immune system must be tamed to prevent rejection.
It’s World PI Week. Patients who have this immune system problem often face a long road to diagnosis.
Primary immunodeficiency (PI) means a person’s immune system has trouble fighting infections.
CSL is partnering with employees to make its biotech business more sustainable with a seven-year plan to reduce environmental…
The Newborn Genomes Programme in the United Kingdom will screen 100,000 babies on a voluntary basis to catch more rare geneti…
Americas
Asia Pacific
Middle East
Europe
